Medication appropriateness for elderly nursing home residents with a limited remaining life expectancy: Adjusting the START/STOPP criteria by means of a Delphi consensus study

C. A. M. Pouw; M. Smalbrugge; C. M. P. M. Hertogh; R. J. van Marum; Jacqueline G. Hugtenburg

Medication appropriateness for elderly nursing home residents with a limited remaining life expectancy: Adjusting the START/STOPP criteria by means of a Delphi consensus study

C. A. M. Pouw, M. Smalbrugge, C. M. P. M. Hertogh, R. J. van Marum, Jacqueline G. Hugtenburg

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	195-195
Journal	Pharmacoepidemiology and drug safety
Volume	27
Publication status	Published - Aug 2018

Cite this

@article{91787034cf7c4e598fa5843c900434b7,

title = "Medication appropriateness for elderly nursing home residents with a limited remaining life expectancy: Adjusting the START/STOPP criteria by means of a Delphi consensus study",

author = "Pouw, {C. A. M.} and M. Smalbrugge and Hertogh, {C. M. P. M.} and {van Marum}, {R. J.} and Hugtenburg, {Jacqueline G.}",

year = "2018",

month = aug,

language = "English",

volume = "27",

pages = "195--195",

journal = "Pharmacoepidemiology and drug safety",

issn = "1053-8569",

publisher = "John Wiley and Sons Ltd",

}

Medication appropriateness for elderly nursing home residents with a limited remaining life expectancy: Adjusting the START/STOPP criteria by means of a Delphi consensus study. / Pouw, C. A. M.; Smalbrugge, M.; Hertogh, C. M. P. M. et al.
In: Pharmacoepidemiology and drug safety, Vol. 27, 08.2018, p. 195-195.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - Medication appropriateness for elderly nursing home residents with a limited remaining life expectancy: Adjusting the START/STOPP criteria by means of a Delphi consensus study

AU - Pouw, C. A. M.

AU - Smalbrugge, M.

AU - Hertogh, C. M. P. M.

AU - van Marum, R. J.

AU - Hugtenburg, Jacqueline G.

PY - 2018/8

Y1 - 2018/8

M3 - Meeting Abstract

SN - 1053-8569

VL - 27

SP - 195

EP - 195

JO - Pharmacoepidemiology and drug safety

JF - Pharmacoepidemiology and drug safety

ER -